Beximco Pharmaceuticals more than doubled its export sales in the first half of its financial year running until 30 June 2019 as the Bangladeshi generics and active pharmaceutical ingredients (APIs) specialist continued to expand its offering in North America.
Having launched its fourth product in the US, metformin 500mg and 750mg extended-release tablets, the company also secured US Food...








